438 resultados para Antiparasitic treatment

Is exenatide advancing the treatment of Type 2 diabetes?

Relevância:

20.00% 20.00%

Publicador:

Veja mais

What are the potential benefits and limitations of particle therapy in the treatment of paediatric malignancies?

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia?

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Readiness for mental health treatment and for changing alcohol use in patients with comorbid psychiatric and alcohol disorders: Are they congruent?

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Arg389Gly-[beta]1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Treatment of cannabis use among people with psychotic or depressive disorders: A systematic review

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Is the cannabinoid CB1 receptor antagonist rimonabant advancing the treatment of obesity?

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Motives for substance use among young people seeking mental health treatment

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Farnesoid X receptor agonism - a new approach to the treatment of cholesterol gallstone disease

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Malignant cord compression: A critical appraisal of prognostic factors predicting functional outcome after surgical treatment

Relevância:

20.00% 20.00%

Publicador:

Veja mais

The safety of lumiracoxib when used in the treatment of arthritis

Relevância:

20.00% 20.00%

Publicador:

Veja mais

Muraglitazar: beneficial or detrimental in the treatment of Type 2 diabetes?

Relevância:

20.00% 20.00%

Publicador:

Veja mais